Evidence map›Paper›PMID 33735408›Full record

ArticleAnalytical and bioanalytical chemistry2021

One-pot high-yield synthesis of Pd nanocubes for Pd-Ir nanocube-based immunoassay of nucleocapsid protein from SARS-CoV-2.

Jiuxing Li, Yingfu Li

Open access · bronzeAbstract read
In one paragraph

Article in Analytical and bioanalytical chemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Jiuxing LiDepartment of Biochemistry and Biomedical Sciences, Michael G. DeGroote Institute of Infectious Disease Research (IIDR), McMaster University, 1280 Main Street West, Hamilton, Ontario, L8S 4K1, Canada.
Yingfu LiDepartment of Biochemistry and Biomedical Sciences, Michael G. DeGroote Institute of Infectious Disease Research (IIDR), McMaster University, 1280 Main Street West, Hamilton, Ontario, L8S 4K1, Canada. liying@mcmaster.ca.
McMaster University · CA

Funding

Natural Sciences and Engineering Research Council of Canada RGPIN-2020-06401
6 · The paper itself

Abstract

Pd-Ir nanocubes are promising peroxidase-mimicking nanozymes for immunoassays, enabled by their excellent stability, relatively high catalytic activity, and reproducible performance. A key step involved in the preparation of Pd-Ir nanocubes is the synthesis of Pd nanocubes. However, the traditional method to synthesize Pd nanocubes requires sophisticated and expensive equipment to precisely control the reaction temperature and highly skilled technicians to achieve satisfactory and reproducible product yields. Herein, we report a simple, cost-effective, high-yield (> 99%) and one-pot strategy to synthesize Pd nanocubes with sizes of 7, 18, and 51 nm for the preparation of Pd-Ir nanocubes. The resulting 18 nm Pd-Ir nanocubes display three orders of magnitude higher peroxidase activity compared to horseradish peroxidase, leading to a significantly increased detection sensitivity when applied in the immunoassay of nucleocapsid protein from SARS-CoV-2. Due to the simplicity in both material synthesis and assaying procedures and the excellent detection sensitivity, our method should allow for the generalized application of Pd-Ir nanocube-based immunoassays for the diagnosis of human diseases.

Indexed as

SARS-CoV-2Antibodies, ViralCoronavirus Nucleocapsid ProteinsCost-Benefit AnalysisCOVID-19HumansImmunoassayIridiumMolecular StructureNanostructuresPalladiumPhosphoproteinsAntibodies, ViralCoronavirus Nucleocapsid ProteinsIridiumnucleocapsid phosphoprotein, SARS-CoV-2PalladiumPhosphoproteinsImmunoassayNucleocapsid proteinOne-potPd-Ir nanocubesPd nanocubesSARS-CoV-2

Identifiers

PMID33735408
PMCPMC7971390
OpenAlexW3138613768

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.